|
|
11.06.25 - 10:45
|
Canopy Growth-Aktie: Eine einzige Achterbahnfahrt (Sharedeals)
|
|
Der Kurs der Canopy Growth-Aktie ist dieser Tage ein einziges Auf und Ab. Seit gut einem Monat schwankt der Cannabistitel zwischen 1,20 und 1,90 US$ wild hin und her. Sind sich Anleger nicht einig, wohin die Reise von Canopy Growth geht? Und ist die Cannabisaktie ein kluges Investment? Reformieren die USA ihre Gesetze? Der Aktienkurs […]
The post Canopy Growth-Aktie: Eine einzige Achterbahnfahrt first appeared on sharedeals.de....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.05.25 - 13:03
|
Canopy Growth Reports Fourth Quarter and Fiscal Year 2025 Financial Results (Business Wire)
|
|
Canada cannabis revenue increased 4% in Q4 FY2025 year-over-year, led by 13% growth in Canada medical cannabis
Reduced total debt by $293 million or 49% during FY2025
Refined strategy, focus and organizational structure expected to accelerate growth in global medical cannabis and improve commercial execution in Canada adult-use cannabis
Additional cost reduction initiatives identified and initiated in Q4 FY2025 are expected to deliver at least $20 million in annualized savings over the next 12-18 monthsSMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (Nasdaq: CGC) today announced its financial results for the fourth quarter ended March 31, 2025 ("Q4 FY2025") and the fiscal year ended March 31, 2025 ("FY2025") and the filing of the Company's Annual Report on Form 10-K for FY2025 (the "Form 10-K"), including the audited consolidated financial statements for FY2025 and the unqualified report ther...
|
|
|
|
|
|